Literature DB >> 23566093

Real-time methylomic aberrations during initiation and progression of induced human mammary epithelial cell tumorigenesis.

Natalie E Mitchell1, MacKenzie L Wilson, Molly S Bray, David K Crossman, Trygve O Tollefsbol.   

Abstract

AIM: Neoplastic transformation provides one of the few existing opportunities to analyze molecular changes in real time during the initiation and progression of breast cancer. MATERIALS &
METHODS: Human mammary epithelial cells underwent neoplastic reprogramming, generating one line of semitransformed, premalignant cells and two separate, temporal lines of fully transformed human mammary epithelial cells (THMECs). An Illumina Infinium HumanMethylation27 BeadChip was used to analyze DNA methylation alterations in 27,578 CpG loci at three consecutive time points over an 80-day (d) transformation period.
RESULTS: The mean β value for semitransformed human mammary epithelial cells CpG loci (0.245) was much greater than for either THMEC-40d (0.055) or THMEC-80d (0.066), indicating a large loss of methylation after neoplastic induction. In addition, 54% of CpG loci were hypermethylated during the THMEC-40d to THMEC-80d transition. We observed that the CpG loci exhibiting DNA methylation changes during early oncogenesis were enriched for biological functions like cellular movement; this was distinctly different than in the later, more progressive stages of the transformation process enriched for processes involving differentiation.
CONCLUSION: The timing of major methylomic changes may be important in directing the cell toward a more cancerous phenotype. In addition, gene-specific hypermethylation appears to silence developmentally related genes, leading to dedifferentiation.

Entities:  

Mesh:

Year:  2013        PMID: 23566093      PMCID: PMC3893889          DOI: 10.2217/epi.13.6

Source DB:  PubMed          Journal:  Epigenomics        ISSN: 1750-192X            Impact factor:   4.778


  39 in total

Review 1.  Gene silencing in cancer in association with promoter hypermethylation.

Authors:  James G Herman; Stephen B Baylin
Journal:  N Engl J Med       Date:  2003-11-20       Impact factor: 91.245

2.  Statistical significance for genomewide studies.

Authors:  John D Storey; Robert Tibshirani
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-25       Impact factor: 11.205

3.  Hypermethylation of CpG islands is more prevalent than hypomethylation across the entire genome in breast carcinogenesis.

Authors:  Jianxin Tan; Yumei Gu; Xiaomei Zhang; Sihong You; Xiaowei Lu; Senqing Chen; Xiao Han; Yujie Sun
Journal:  Clin Exp Med       Date:  2012-01-04       Impact factor: 3.984

4.  Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells.

Authors:  B Elenbaas; L Spirio; F Koerner; M D Fleming; D B Zimonjic; J L Donaher; N C Popescu; W C Hahn; R A Weinberg
Journal:  Genes Dev       Date:  2001-01-01       Impact factor: 11.361

5.  Creation of human tumour cells with defined genetic elements.

Authors:  W C Hahn; C M Counter; A S Lundberg; R L Beijersbergen; M W Brooks; R A Weinberg
Journal:  Nature       Date:  1999-07-29       Impact factor: 49.962

6.  DNA hypomethylation in breast cancer: an independent parameter of tumor progression?

Authors:  J Bernardino; C Roux; A Almeida; N Vogt; A Gibaud; M Gerbault-Seureau; H Magdelenat; C A Bourgeois; B Malfoy; B Dutrillaux
Journal:  Cancer Genet Cytogenet       Date:  1997-09

Review 7.  The fundamental role of epigenetic events in cancer.

Authors:  Peter A Jones; Stephen B Baylin
Journal:  Nat Rev Genet       Date:  2002-06       Impact factor: 53.242

8.  Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers.

Authors:  J G Herman; A Merlo; L Mao; R G Lapidus; J P Issa; N E Davidson; D Sidransky; S B Baylin
Journal:  Cancer Res       Date:  1995-10-15       Impact factor: 12.701

9.  A genetically defined model for human ovarian cancer.

Authors:  Jinsong Liu; Gong Yang; Jennifer A Thompson-Lanza; Armand Glassman; Kimberly Hayes; Andrea Patterson; Rebecca T Marquez; Nelly Auersperg; Yinhua Yu; William C Hahn; Gordon B Mills; Robert C Bast
Journal:  Cancer Res       Date:  2004-03-01       Impact factor: 12.701

10.  Global DNA hypomethylation in breast carcinoma: correlation with prognostic factors and tumor progression.

Authors:  J Soares; A E Pinto; C V Cunha; S André; I Barão; J M Sousa; M Cravo
Journal:  Cancer       Date:  1999-01-01       Impact factor: 6.860

View more
  2 in total

1.  Hsa-miR-520d induces hepatoma cells to form normal liver tissues via a stemness-mediated process.

Authors:  Satoshi Tsuno; Xinhui Wang; Kohei Shomori; Junichi Hasegawa; Norimasa Miura
Journal:  Sci Rep       Date:  2014-01-24       Impact factor: 4.379

2.  Combinatorial epigenetic mechanisms and efficacy of early breast cancer inhibition by nutritive botanicals.

Authors:  Yuanyuan Li; Phillip Buckhaults; Xiangqin Cui; Trygve O Tollefsbol
Journal:  Epigenomics       Date:  2016-08-01       Impact factor: 4.778

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.